ArticleJSAMS plus2025
Pre-race medical screening and harm reduction approaches in ultra-endurance racing: A descriptive pilot study of global practice.
Article in JSAMS plus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- TheFrontiers in physiology · 2026Pooled it
- Focus on female athletes and special issue on physical activity in people with disability.JSAMS plus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The rapidly expanding popularity of ultra-endurance racing warrants an analysis of current safety protocols. The literature highlights various risks linked to participating in these events, including sudden cardiac death, electrolyte imbalance, kidney injury and exertional heat stroke. Where guidelines recommend exercise pre-screening, global implementation has not yet been described. This study aims to explore the prevalence of pre-race screening and harm reduction across the global ultra-racing industry. Methods: This pilot observational study audited 200 ultra-races across 67 countries, spanning all continents and five race modalities. A comprehensive search strategy examined publicly available information, gathering 40 data points per race, including 22 pre-race screening and harm reduction metrics, as communicated at the point of registration. Results were then reviewed for concordance with relevant international guidelines. Results: This study found that a quarter (24 %) of ultra-races did not employ any medically relevant pre-race screening or harm reduction strategies (point of registration). A strong bias was identified favouring individual assumption of liability. Where screening occurred, approaches were generally inconsistent with guidelines and did not account for the specific risks imposed by race location, climate or duration. Less than one third (29 %) of ultra-races specified endurance experience as an entry requirement. More comprehensive screening was observed in South America and among high-altitude races (>2500 m). Conclusions: This study highlights opportunities to improve athlete safety broadly across ultra-racing. Such events carry unique physiological risks. Here, existing pre-race approaches seemingly fall short of recommended practice. By establishing clearer benchmarks, targeted improvements will become possible. This will promote sustainable practices in what promises to remain a popular exercise industry in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.